TMCITREACE MEDICAL CONCEPTS, INC.同业对比
TREACE MEDICAL CONCEPTS, INC. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMCI本股 | $280M#8 | — | 4.1x#9 | 1.3x#3 | 1.6%#10 | -5.8%#9 | -25.5%#8 | -87.1%#12 | -47.4%#9 | 2#11 | -34.7%#7 | — |
| SI | $407M#1 | 0.1x#1 | 3.3x#6 | 8.6x#14 | 49.6%#4 | -158.4%#14 | -55.6%#10 | -32.5%#9 | -22.9%#7 | 3#10 | 73.6%#2 | — |
| CARL | $402M#2 | 134.0x#7 | 4.8x#11 | 8.0x#12 | 85.9%#2 | -22.2%#11 | -60.5%#12 | -35.2%#10 | -57.3%#11 | 5#4 | 19.0%#6 | — |
| OFIX | $360M#3 | — | 0.8x#2 | 0.4x#2 | 2.9%#9 | 26.8%#6 | -9.9%#7 | -21.5%#7 | -14.9%#6 | 5#4 | -44.9%#8 | — |
| EMBC | $349M#4 | 4.2x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#7 | 22.4%#2 | — | 27.0%#1 | 6#3 | -49.5%#10 | 10.0%#1 |
| MOBI | $344M#5 | — | 2.0x#5 | — | — | — | — | 0.0%#5 | — | — | — | — |
| OBIO | $340M#6 | — | 3.4x#7 | 10.2x#15 | 1169.2%#1 | 13.6%#8 | -154.7%#15 | -52.8%#11 | -54.9%#10 | — | 51.1%#3 | 5.9%#2 |
| CLPT | $311M#7 | — | 11.4x#13 | 8.4x#13 | 17.8%#5 | -35.0%#13 | -65.4%#14 | -93.7%#13 | — | — | -49.0%#9 | — |
| CTSO | $258M#9 | — | — | 7.0x#11 | 4.1%#8 | 60.4%#4 | -39.8%#9 | — | -122.1%#12 | 4#8 | -72.5%#11 | — |
| ANIK | $257M#10 | — | 1.9x#4 | 2.3x#6 | -5.9%#13 | 80.4%#3 | -9.8%#6 | -8.0%#6 | -8.8%#5 | 4#8 | 95.1%#1 | — |
| INFU | $249M#11 | 31.3x#6 | 4.2x#10 | 1.7x#4 | 6.4%#7 | 182.6%#2 | 8.3%#5 | 11.2%#3 | 9.5%#4 | 9#1 | 20.9%#5 | — |
| OSUR | $248M#12 | — | 0.8x#1 | 2.2x#5 | -38.1%#15 | -252.5%#15 | -62.6%#13 | -21.6%#8 | -43.8%#8 | — | 35.2%#4 | — |
| IDXG | $240M#13 | 9.9x#3 | 10.3x#12 | 6.2x#10 | -17.5%#14 | 267.2%#1 | 10.5%#4 | 105.8%#1 | 14.2%#3 | 5#4 | — | — |
| UTMD | $226M#14 | 21.6x#5 | 1.8x#3 | 5.9x#9 | -5.8%#12 | -18.7%#10 | 29.6%#1 | 9.2%#4 | — | — | — | 1.8%#3 |
| TLSI | $218M#15 | — | 33.3x#14 | 4.8x#8 | 53.4%#3 | -30.6%#12 | -59.7%#11 | -598.9%#14 | — | 5#4 | — | — |
| PDEX | $194M#16 | 16.7x#4 | 3.9x#8 | 2.5x#7 | 16.5%#6 | 52.2%#5 | 16.8%#3 | 27.7%#2 | 17.9%#2 | 7#2 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议